Intravenous administration of zidovudine (ZDV) during labour is a key step for vertical HIV transmission (VT) prevention, but there is no evidence of benefit when maternal HIV-RNA at delivery is <50 copies/mL. The aim of this study is evaluating the appropriateness of intrapartum ZDV use in Italy.
Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy
Taramasso, Lucia;Bovis, Francesca;Di Biagio, Antonio;Bassetti, Matteo;
2022-01-01
Abstract
Intravenous administration of zidovudine (ZDV) during labour is a key step for vertical HIV transmission (VT) prevention, but there is no evidence of benefit when maternal HIV-RNA at delivery is <50 copies/mL. The aim of this study is evaluating the appropriateness of intrapartum ZDV use in Italy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy.pdf
accesso chiuso
Tipologia:
Documento in Post-print
Dimensione
483.62 kB
Formato
Adobe PDF
|
483.62 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
